Production (Stage)
Kewaunee Scientific Corporation
KEQU
$58.45
-$0.69-1.17%
NASDAQ
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 18.02% | 9.44% | -7.18% | -7.71% | -7.17% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.02% | 9.44% | -7.18% | -7.71% | -7.17% |
| Cost of Revenue | 13.12% | 4.76% | -13.30% | -15.86% | -17.51% |
| Gross Profit | 32.29% | 24.46% | 15.27% | 27.40% | 46.26% |
| SG&A Expenses | 50.61% | 37.52% | 14.09% | 12.16% | 11.99% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.98% | 10.49% | -8.91% | -11.61% | -13.34% |
| Operating Income | -2.01% | -3.29% | 18.04% | 78.54% | 242.40% |
| Income Before Tax | 12.70% | -36.26% | -11.20% | 47.12% | 191.66% |
| Income Tax Expenses | 153.92% | -272.43% | -251.74% | -281.65% | -289.17% |
| Earnings from Continuing Operations | -39.22% | 98.56% | 151.63% | 308.88% | 1,302.28% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 41.45% | 2.50% | 64.01% | 51.42% | 51.05% |
| Net Income | -39.18% | 101.34% | 170.38% | 366.58% | 2,441.06% |
| EBIT | -2.01% | -3.29% | 18.04% | 78.54% | 242.40% |
| EBITDA | 4.66% | 2.57% | 16.90% | 63.27% | 160.39% |
| EPS Basic | -38.98% | 102.68% | 170.88% | 363.42% | 2,427.22% |
| Normalized Basic EPS | -12.35% | -7.38% | 27.55% | 113.92% | 367.63% |
| EPS Diluted | -39.67% | 98.59% | 165.61% | 359.73% | 2,727.17% |
| Normalized Diluted EPS | -14.00% | -9.32% | 25.21% | 112.36% | 373.01% |
| Average Basic Shares Outstanding | -0.58% | -0.30% | 0.43% | 1.35% | 1.92% |
| Average Diluted Shares Outstanding | 1.40% | 1.70% | 1.91% | 2.43% | 2.41% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |